Viatris And Sandoz May Market Injectafer Generic In US From 2026

ANDA Disputes Regarding Ferric Carboxymaltose Are Now Settled

 
• By Chloe Kent
  
2026 sign
Viatris’ Mylan unit and Sandoz will have licenses to market generic ferric carboxymaltose products in the US from 1 July 2026 • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products